Posts Tagged ‘CNF Board of Directors’

Welcome to the Board – Donald Pearl

Posted on:

In late 2019, two new members joined the CNF Board of Directors. One of those members is Donald Pearl. This membership marks a momentous occasion, as Mr. Pearl is the first CNF BOD member from industry. CNF has always believed that convening a multi-stakeholder perspective can only make us stronger,…  Read More

Welcome to the Board – Dr. Scott Perry

Posted on:

Late in 2019, CNF was lucky enough to have two new members join our Board of Directors. You may know him from twitter, as @TheNotoriousEEG, but we know him as Dr. Scott Perry. To give you a little more insight into Dr. Perry’s career, and what inspired him to join…  Read More

Getting to Know the CNF Team – Anup Patel, MD

Posted on:

Welcome back to our weekly interview series! Each week, we share an interview with a member of the CNF community. Today, we’re highlighting the work of Anup Patel, a physician who sits on our Board of Directors. Tell us what you do in your day job  I am the section…  Read More

Getting to know the CNF team – Sue Yudovin

Posted on:

Every week, we’re profiling members of the CNF community so you can get to know the people behind our organization’s mission. Meet Sue Yudovin, a former pediatric nurse who sits on our Board of Directors. Tell us what you do in your day job? I am a retired certified pediatric…  Read More

Getting to know the CNF team – Phillip Pearl, MD

Posted on:

Every week, we’re sharing an interview with the a member of the CNF community, starting with our staff, Board of Directors. This week, get to know Phillip Pearl, MD, a member of CNF’s Board. Tell us what you do in your day job. Direct the epilepsy program (clinical, research, educational/fellowship,…  Read More

Getting to know the CNF Team – Stephen M. Peters

Posted on:

This week on the blog, we’re getting to know one of the members of our Board of Directors. Meet Stephen Peters. Tell us what you do in your day job I’m a Partner at Brookfield Financial, a large Global Investment Bank.  I am responsible for managing the western U.S. where…  Read More

CNF’s Statement on the FDA’s May 31st CBD Hearing

Posted on:

On May 31st, 2019, the FDA held a public hearing, “to obtain scientific data and information about the safety, manufacturing, product quality, marketing, labeling, and sale of products containing cannabis or cannabis-derived compounds.” In advance of this hearing, the CNF Board of Directors formally submitted the following statement to the FDA.   Read More